These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 21995687)

  • 1. HDL: who needs it?
    Wierzbicki AS
    Int J Clin Pract; 2011 Nov; 65(11):1111-3. PubMed ID: 21995687
    [No Abstract]   [Full Text] [Related]  

  • 2. Niacin: the only vitamin that reduces cardiovascular events.
    Wierzbicki AS
    Int J Clin Pract; 2011 Apr; 65(4):379-85. PubMed ID: 21401825
    [No Abstract]   [Full Text] [Related]  

  • 3. The facts behind niacin.
    Hochholzer W; Berg DD; Giugliano RP
    Ther Adv Cardiovasc Dis; 2011 Oct; 5(5):227-40. PubMed ID: 21893559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [What is the future for niacin after the AIM-HIGH study?].
    Cybulska B; Kłosiewicz Latoszek L
    Kardiol Pol; 2012; 70(3):315-6. PubMed ID: 22430425
    [No Abstract]   [Full Text] [Related]  

  • 5. Trial clouds use of niacin with a statin.
    Harv Heart Lett; 2011 Aug; 21(12):2. PubMed ID: 21991606
    [No Abstract]   [Full Text] [Related]  

  • 6. New thinking on niacin use. Using niacin to raise "good" cholesterol doesn't lower your risk of having a heart attack or stroke.
    Harv Health Lett; 2014 Aug; 39(10):6. PubMed ID: 25230410
    [No Abstract]   [Full Text] [Related]  

  • 7. What does the future hold for niacin as a treatment for hyperlipidaemia and cardiovascular disease?
    Ahmed MH
    J Cardiovasc Med (Hagerstown); 2010 Nov; 11(11):858-60. PubMed ID: 20686417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New focus on raising HDL "good" cholesterol. But the value of this is not entirely clear.
    Duke Med Health News; 2012 Feb; 18(2):3. PubMed ID: 22397008
    [No Abstract]   [Full Text] [Related]  

  • 9. Niacin: its value in raising HDL cholesterol is being questioned.
    Heart Advis; 2011 Oct; 14(10):7. PubMed ID: 23019714
    [No Abstract]   [Full Text] [Related]  

  • 10. Efficacy and tolerability of extended-release niacin/laropiprant in dyslipidemic patients with metabolic syndrome.
    Bays HE; Shah A; Lin J; McCrary Sisk C; Paolini JF; Maccubbin D
    J Clin Lipidol; 2010; 4(6):515-21. PubMed ID: 21122699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Niacin into the void. Failure of HDL cholesterol drug may B this vitamin's big chance.
    Harv Health Lett; 2007 Apr; 32(6):6. PubMed ID: 17390509
    [No Abstract]   [Full Text] [Related]  

  • 12. Search and rescue for hypotheses surviving AIM-HIGH, the niacin therapy earthquake: still problematic after the primary publication.
    Brinton EA
    J Clin Lipidol; 2012; 6(4):312-7. PubMed ID: 22836067
    [No Abstract]   [Full Text] [Related]  

  • 13. The addition of niacin to statin therapy improves high-density lipoprotein cholesterol levels but not metrics of functionality.
    Khera AV; Patel PJ; Reilly MP; Rader DJ
    J Am Coll Cardiol; 2013 Nov; 62(20):1909-10. PubMed ID: 23933538
    [No Abstract]   [Full Text] [Related]  

  • 14. 'Trig-onometry': non-high-density lipoprotein cholesterol as a therapeutic target in dyslipidaemia.
    Jacobson TA
    Int J Clin Pract; 2011 Jan; 65(1):82-101. PubMed ID: 21105969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A case report of a diabetic woman with very low HDL cholesterol.
    Chaychi L; Kinlaw WB; Asztalos BF; Schaefer EJ
    J Clin Lipidol; 2010; 4(2):133-5. PubMed ID: 21122641
    [No Abstract]   [Full Text] [Related]  

  • 16. The effects of simvastatin-niacin and antioxidant therapy on HDL.
    Drown DJ
    Prog Cardiovasc Nurs; 2002; 17(2):102-3. PubMed ID: 11986546
    [No Abstract]   [Full Text] [Related]  

  • 17. Niacin--a case study for the role of event-driven versus surrogate endpoint trials.
    Blaha MJ; Michos ED
    Heart; 2013 Nov; 99(22):1631-2. PubMed ID: 24041650
    [No Abstract]   [Full Text] [Related]  

  • 18. HDL cholesterol--how do I raise my patients good cholesterol?
    Shaikh Q; Kamal AK
    J Pak Med Assoc; 2012 Jun; 62(6):623-4. PubMed ID: 22755358
    [No Abstract]   [Full Text] [Related]  

  • 19. [Alternative drugs to statins].
    Scheen AJ
    Rev Prat; 2011 Oct; 61(8):1121-2. PubMed ID: 22135982
    [No Abstract]   [Full Text] [Related]  

  • 20. Avoid no-flush niacin in favor of the prescription version. Follow certain steps to reduce the flushing effects of prescription niacin.
    Heart Advis; 2010 Nov; 13(11):5. PubMed ID: 22834056
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.